Projects per year
Personal profile
Courses
Seminar
Signal Transduction
Cellular Physiology and Molecular Pharmacology
Medical Pharmacology
Pharmacology
Pharmacology Laboratory
Signal Transduction
Cellular Physiology and Molecular Pharmacology
Medical Pharmacology
Pharmacology
Pharmacology Laboratory
Education
Ph.D., University of Cambridge,UK
Keywords
- ATP-binding cassette ( ABC ) transporters
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Chung-Pu Wu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigating the Drug-Nutrient Interaction of Bioactive Compounds in Dietary Supplements Mediated by the Atp-Binding Cassette Transporters
Wu, C.-P. (PI) & Hung, T.-H. (CoPI)
01/08/25 → 31/07/26
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Investigating the Drug-Nutrient Interaction of Bioactive Compounds in Dietary Supplements Mediated by Inhibition and Induction of the Atp-Binding Cassette Transporters Abcb1 and Abcg2
Wu, C.-P. (PI) & Hung, T.-H. (CoPI)
01/08/24 → 31/07/25
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Identification of Inhibitors of Abcb1 Using Molecular Docking-Guided Drug Repositioning Approaches
Wu, C.-P. (PI)
01/08/23 → 31/07/24
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
Evaluation of Multidrug Resistance-Linked Atp-Binding Cassette Drug Transporter-Mediated Drug-Drug Interactions of Molecularly Targeted Agents in Combination Chemotherapy
Wu, C.-P. (PI)
01/08/22 → 31/07/23
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
-
A Systematic Approach to Identify Novel Inhibitors of Multidrug-Resistance Associated Proteins from Purified Natural Products: Drug Screening, in Vitro and in Vivo Model Systems
Wu, C.-P. (PI)
01/08/21 → 31/07/22
Project: National Science and Technology Council › National Science and Technology Council Academic Grants
Research output
-
Attenuation of ABCG2-dependent drug efflux by befotertinib restores chemosensitivity in multidrug-resistant non-small cell lung cancer cells
Li, Y. C., Chen, T. Y., Chuang, H. C., Lin, B. H., Murakami, M., Chang, Y. T., Wu, Y. S., Hung, T. H., Ambudkar, S. V. & Wu, C. P., 07 2026, In: Biomedicine and Pharmacotherapy. 200, 119613.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
Befotertinib restored chemosensitivity to multidrug-resistant cancer cells by inhibiting the drug efflux activity of ABCB
Li, Y. C., Murakami, M., Huang, Y. H., Wu, Y. S., Hung, T. H., Ambudkar, S. V. & Wu, C. P., 01 03 2026, In: Journal of Pharmacy and Pharmacology. 78, 3, rgag020.Research output: Contribution to journal › Journal Article › peer-review
-
Erratum to "The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs" [European Journal of Pharmaceutical Sciences (2025) 107337]
Li, Y. C., Lin, B. H., Murakami, M., Wu, Y. S., Hung, T. H., Ambudkar, S. V. & Wu, C. P., 01 01 2026, In: European Journal of Pharmaceutical Sciences. 216, p. 107384 107384.Research output: Contribution to journal › Comment/debate
Open Access -
Lirafugratinib attenuates ABCG2-dependent drug efflux and restores chemosensitivity in multidrug-resistant nonsmall cell lung cancer cells
Wu, C. P., Li, Y. C., Lin, B. H., Murakami, M., Chang, Y. T., Wu, Y. S., Hung, T. H. & Ambudkar, S. V., 04 2026, In: Drug Metabolism and Disposition. 54, 4, p. 100258 100258.Research output: Contribution to journal › Journal Article › peer-review
Open Access -
The fourth-generation EGFR tyrosine kinase inhibitor BLU-945 resensitizes ABCG2-overexpressing multidrug-resistant non-small cell lung cancer cells to cytotoxic anticancer drugs
Li, Y. C., Lin, B. H., Murakami, M., Wu, Y. S., Hung, T. H., Ambudkar, S. . & Wu, C. P., 01 12 2025, In: European Journal of Pharmaceutical Sciences. 215, p. 107337 107337.Research output: Contribution to journal › Journal Article › peer-review
Open Access
Activities
- 2 Participating in a conference, workshop, ...
-
第144屆日本藥學會年會
Wu, C.-P. (Participant)
28 03 2024 → 31 03 2024Activity: Participating in or organizing an event › Participating in a conference, workshop, ...
-
The 82nd Annual Meeting of The Japanese Cancer Association
Wu, C.-P. (Participant)
21 09 2023 → 23 09 2023Activity: Participating in or organizing an event › Participating in a conference, workshop, ...
Prizes
-
2024 World's Top 2% Scientists- Single-year Impact
Wu, C.-P. (Recipient), 2024
Prize: World's Top 2% Scientists › World's Top 2% Scientists:Single-year Impact
-
2025 World's Top 2% Scientists-Single-year Impact
Wu, C.-P. (Recipient), 2025
Prize: World's Top 2% Scientists › World's Top 2% Scientists:Single-year Impact